Baroness Walmsley (LD)

My Lords, as I understand it, following the Royal Assent of this Bill, there will be more consultations on many of the regulations the Government plan to bring forward. The call for evidence, which was published on 8 October, is already seeking evidence on some of the more technical aspects of the Bill. I point out to those who tabled these amendments that the UK Government are a signatory to Article 5.3 of the WHO’s Framework Convention on Tobacco Control, which aims to protect health policy-making from tobacco industry influence. That is why I think that there should be no further mandation for consultation with those who have a vested interest in producing or selling tobacco products, as long as we keep an eye on small retailers. As far as the bulk of their sales of products containing tobacco—I choose the way I express it very carefully—are concerned, there will be a small impact because only a one-year cohort at a time, which is a relatively small amount, will be prevented from being sold these products. As I said on our previous day in Committee, that will give small retailers plenty of time to adjust their sales models. We will deal with things such as age verification, as well as other issues that may cause small retailers concern, in our debates on other groups; we must do that rigorously. I point out that there is nothing to stop tobacco companies responding to past and current government consultations on proposed regulations, but, of course, all respondents are required under the WHO convention to be transparent about their direct or indirect industry links. This is appropriate given their commercial conflicts of interest, which are sometimes in direct conflict with the Government’s public health objective to eliminate smoking over a generation.